• Keine Ergebnisse gefunden

PET/CT Scanner Validation

N/A
N/A
Protected

Academic year: 2022

Aktie "PET/CT Scanner Validation"

Copied!
2
0
0

Wird geladen.... (Jetzt Volltext ansehen)

Volltext

(1)

s

s

THE CLINICAL TRIALS NETWORK PROGRAM

PET/CT Scanner Validation

Thank you for your interest in the CTN Scanner Validation Program. A successful validation ensures that your study patients as well as your clinical patients are being scanned on a quantitatively and qualitatively accurate PET/CT.

Overview

The CTN’s Scanner Validation Program was established to ensure the quantitative accuracy of PET/CT scanners used in multicenter trials. The phantom was designed as a clinical simulator to evaluate the detection of lesions in an anthropomorphic model. Since inception, the program has collected nearly 500 phantom data sets from nearly 200 imaging sites sampling the spectrum of commercially available PET/CT systems1. This data set has allowed the CTN to develop acceptance criteria to determine quantitative acceptance of PET imaging acquired in multicenter studies. Below are the main goals of the program:

To provide relevant and meaningful assurances to trial sponsors that PET/CT scanners in their trials will perform quantitatively and qualitatively above predetermined standards, rationally set, based upon seven years of data collection and analysis.

To globally raise the bar for quantitative PET/CT imaging in clinical trials and clinical practice.

To provide constructive feedback to imaging sites regarding their scanner’s performance characteristics based upon our historical collected data.

Scanner Validation Process

Scanner validation

requires the use of the unique CTN phantom; i.e., a

“clinical simulator” that mimics lesions in the human torso and provides both qualitative and quantitative information in conditions similar to actual clinical imaging settings.

To be validated, staff at imaging centers must successfully complete the steps in the process illustrated below for each PET/CT scanner being tested.

CTN reviews phantom images and worksheet Validated; Site receives

report and Certificate Site returns CTN phantom

Site /Sponsor requests scanner validation

s s

Site completes and returns PET/CT Equipment form

provided by CTN

s

CTN Initiates phantom shipment

s

Site performs phantom scan; uploads/sends images and worksheet

1John J. Sunderland and Paul E. Christian; Quantitative PET/CT Scanner Performance Characterization Based Upon the Society of Nuclear Medicine and Molecular Imaging Clinical Trials Network Oncology Clinical Simulator Phantom; J Nucl Med 2015 56:145-152

(2)

Review Analysis

Two reviewers will perform the image review, including at least one PhD-level physicist specifically trained in scanner validation. If images meet all required parameters, the validation is considered successful. A scanner performance report is prepared and sent to the site along with a Certificate of Validation. This scanner performance report includes an evaluation of the scanner’s lesion detection ability, technical and quantitative assessment. You will also receive a comparative analysis (pictured below) of your scanner to scanners of the same model, along with suggestions, if needed, to improve the quality and/or accuracy of the images.

THE CLINICAL TRIALS NETWORK PROGRAM

PET/CT Scanner Validation

*The comparative analysis plot above indicates how a site’s scanner performed quantitatively in this current validation exercise and how it compares – lesion by lesion – to other scanners in the same model group.

GE-690-710 Series Average sApplicants SUV

s

s

s

• •

s

5.00 4.50 4.00 3.50 3.00 2.50 2.00 1.50 1.00 0.50 0.00

s

s

GE-690-710 Series

SUV

Shoulder 15 mm Rt Lung 10 mm Left Lung 10 mm Axillary LN 10 mm

Left Lung 20 mm

Scanner Validation Fees

Categories Fees

Initial Validation $2,000 up to 2 scanners

$500 each additional scanner

CTN Phantom Shipping Shipping fees vary by location

Re-validation $1,000 up to 2 scanners

Note: If failed more than once, site will be charged for $500 per scanner for an additional attempt. If a previously-validated scanner was validated more than 18 months ago, you will be billed as an Initial Validation.

Contact

Bonnie Clarke, Director:

bclarke@snmmi.org or 703-667-5120 Shyanne Mortimer, Imaging Research Specialist:

smortimer@snmmi.org or 703-326-1180

Jina Kim, Associate Program Manager: jkim@snmmi.org or 703-652-6795

Referenzen

ÄHNLICHE DOKUMENTE

Was die Autoren unerwähnt lassen, ist das Ergebnis der einzigen RCT zur PET-Diagnostik bei malignen Lymphomen: Hier hatte sich näm- lich ein Hinweis auf einen Nachteil der

1 Department of Data Science and Machine Learning, EXINI Diagnostics AB, Lund, Sweden; 2 Radiation Oncology Service, VA Greater Los Angeles Healthcare System, Los Angeles, CA;

In-house manufactured anthropomorphic and tissue equivalent phantoms in par- ticular are often featured in a dedicated publication to describe the phantom design and manufacture,

Klinik und Poliklinik für Nuklearmedizin KLINIKUM DER UNIVERSITÄT MÜNCHEN ®

Da die histologische Sicherung zum Beispiel mittels videoassistierter Tho- rakoskopie (VATS) oder transthoraka- ler Feinnadelbiopsie mit einem etwa 19 bis 26-Prozentigen Risiko

Bildgebende Verfahren sind heute für die Erkennung und Behandlung unterschiedlichster Erkrankungen unverzichtbar.. Bei einer PET/CT-Untersuchung werden die Methoden

Obwohl in der deutschen Übersetzung die Hälfte einer Seite (von 445 Seiten!) zwei- mal abgedruckt ist und die zweite Hälfte fehlt, so daß kurzfristig dem Leser der Fa-

Der zusätzlich aufgenommene / im Körper her- gestellte Zucker würde die Untersuchung so sehr stören, dass wir sie nicht durchführen können.. Der bei Ihnen verwendete Zucker